{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:08:35Z","timestamp":1792130915191,"version":"4.4.0"},"reference-count":63,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:p>Life is about timing. \u2014Carl Lewis<\/jats:p>\n               <jats:p>The understanding of autoimmune type 1 diabetes is increasing, and examining etiology separate from pathogenesis has become crucial. The components to explain type 1 diabetes development have been known for some time. The strong association with HLA has been researched for nearly 50 years. Genome-wide association studies added another 60+ non-HLA genetic factors with minor contribution to risk. Insulitis has long been known to be present close to clinical diagnosis. T and B cells recognizing \u03b2-cell autoantigens are detectable prior to diagnosis and in newly diagnosed patients. Islet autoantibody tests against four major autoantigens have been standardized and used as biomarkers of islet autoimmunity. However, to clarify the etiology would require attention to time. Etiology may be defined as the cause of a disease (i.e., type 1 diabetes) or abnormal condition (i.e., islet autoimmunity). Timing is everything, as neither the prodrome of islet autoimmunity nor the clinical onset of type 1 diabetes tells us much about the etiology. Rather, the islet autoantibody that appears first and persists would mark the diagnosis of an autoimmune islet disease (AID). Events after the diagnosis of AID would represent the pathogenesis. Several islet autoantibodies without (stage 1) or with impaired glucose tolerance (stage 2) or with symptoms (stage 3) would define the pathogenesis culminating in clinical type 1 diabetes. Etiology would be about the timing of events that take place before the first-appearing islet autoantibody.<\/jats:p>","DOI":"10.2337\/dbi18-0034","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T20:40:43Z","timestamp":1624308043000},"page":"1431-1439","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":21,"title":["Etiology of Autoimmune Islet Disease: Timing Is Everything"],"prefix":"10.2337","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-0499","authenticated-orcid":false,"given":"\u00c5ke","family":"Lernmark","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Lund University Clinical Research Centre, Sk\u00e5ne University Hospital, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"2022031309284172500_B1","volume-title":"The Discovery of Insulin","author":"Bliss","year":"1982"},{"key":"2022031309284172500_B2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa012350","article-title":"Effects of insulin in relatives of patients with type 1 diabetes mellitus","volume":"346","author":"Diabetes Prevention Trial\u2013Type 1 Diabetes Study Group","year":"2002","journal-title":"N Engl J Med"},{"key":"2022031309284172500_B3","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"2022031309284172500_B4","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/dc19-2547","article-title":"Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY study","volume":"43","author":"Vehik","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031309284172500_B5","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/dc15-2292","article-title":"Prognostic classification factors associated with development of multiple autoantibodies, dysglycemia, and type 1 diabetes\u2013a recursive partitioning analysis","volume":"39","author":"Xu","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031309284172500_B6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diacare.28.5.1068","article-title":"Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial\u2013Type 1","volume":"28","author":"Skyler","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031309284172500_B7","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2017.17070","article-title":"Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes: a randomized clinical trial","volume":"318","author":"Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group","year":"2017","journal-title":"JAMA"},{"key":"2022031309284172500_B8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"2022031309284172500_B9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jama.2019.21565","article-title":"Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany","volume":"323","author":"Ziegler","year":"2020","journal-title":"JAMA"},{"key":"2022031309284172500_B10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MED.0000000000000173","article-title":"General population screening for type 1 diabetes: has its time come?","volume":"22","author":"Insel","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2022031309284172500_B11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2337\/diab.14.10.619","article-title":"Pathologic anatomy of the pancreas in juvenile diabetes mellitus","volume":"14","author":"Gepts","year":"1965","journal-title":"Diabetes"},{"key":"2022031309284172500_B12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(70)90195-9","article-title":"Autoimmunity in diabetes mellitus","volume":"2","author":"Nerup","year":"1970","journal-title":"Lancet"},{"key":"2022031309284172500_B13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0140-6736(74)91201-X","article-title":"HL-A antigens and diabetes mellitus","volume":"2","author":"Nerup","year":"1974","journal-title":"Lancet"},{"key":"2022031309284172500_B14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","article-title":"Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies","volume":"2","author":"Bottazzo","year":"1974","journal-title":"Lancet"},{"key":"2022031309284172500_B15","first-page":"345","article-title":"Immunosuppression of acute insulin-dependent diabetics","volume-title":"Immunology of Diabetes","author":"Leslie","year":"1980"},{"key":"2022031309284172500_B16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(85)91964-6","article-title":"Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus","volume":"1","author":"Assan","year":"1985","journal-title":"Lancet"},{"key":"2022031309284172500_B17","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/diab.37.11.1574","article-title":"Cyclosporin-induced remission of IDDM after early intervention: association of 1 yr of cyclosporin treatment with enhanced insulin secretion","volume":"37","author":"The Canadian-European Randomized Control Trial Group","year":"1988","journal-title":"Diabetes"},{"key":"2022031309284172500_B18","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1056\/NEJM199206183262502","article-title":"Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases","volume":"326","author":"Feutren","year":"1992","journal-title":"N Engl J Med"},{"key":"2022031309284172500_B19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1742-1241.2010.02580.x","article-title":"Immune intervention for type 1 diabetes mellitus","volume":"170","author":"Skyler","year":"2011","journal-title":"Int J Clin Pract Suppl"},{"key":"2022031309284172500_B20","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031309284172500_B21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2337\/diab.45.7.967","article-title":"Perinatal autoimmunity in offspring of diabetic parents. The German multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood","volume":"45","author":"Roll","year":"1996","journal-title":"Diabetes"},{"key":"2022031309284172500_B22","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2337\/db13-0300","article-title":"Patterns of \u03b2-cell autoantibody appearance and genetic associations during the first years of life","volume":"62","author":"Ilonen","year":"2013","journal-title":"Diabetes"},{"key":"2022031309284172500_B23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","article-title":"The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study","volume":"58","author":"Krischer","year":"2015","journal-title":"Diabetologia"},{"key":"2022031309284172500_B24","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/dc16-0181","article-title":"Reversion of \u03b2-cell autoimmunity changes risk of type 1 diabetes: TEDDY study","volume":"39","author":"Vehik","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031309284172500_B25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2337\/diab.36.5.578","article-title":"Progress toward standardization of cytoplasmic islet cell-antibody assay","volume":"36","author":"Gleichmann","year":"1987","journal-title":"Diabetes"},{"key":"2022031309284172500_B26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1373\/clinchem.2019.304196","article-title":"Islet Autoantibody Standardization Program 2018 Workshop: interlaboratory comparison of glutamic acid decarboxylase autoantibody assay performance","volume":"65","author":"Lampasona","year":"2019","journal-title":"Clin Chem"},{"key":"2022031309284172500_B27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s43441-020-00255-8","article-title":"Effective data sharing as a conduit for advancing medical product development","volume":"55","author":"Karpen","year":"2021","journal-title":"Ther Innov Regul Sci"},{"key":"2022031309284172500_B28","doi-asserted-by":"crossref","first-page":"e028578","DOI":"10.1136\/bmjopen-2018-028578","article-title":"Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (Global Platform for the Prevention of Autoimmune Diabetes Primary Oral Insulin Trial) study protocol","volume":"9","author":"Ziegler","year":"2019","journal-title":"BMJ Open"},{"key":"2022031309284172500_B29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.conb.2013.04.013","article-title":"The autoimmune basis of narcolepsy","volume":"23","author":"Mahlios","year":"2013","journal-title":"Curr Opin Neurobiol"},{"key":"2022031309284172500_B30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/BF02221683","article-title":"Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children","volume":"35","author":"Landin-Olsson","year":"1992","journal-title":"Diabetologia"},{"key":"2022031309284172500_B31","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","article-title":"Prospective virome analyses in young children at increased genetic risk for type 1 diabetes","volume":"25","author":"Vehik","year":"2019","journal-title":"Nat Med"},{"key":"2022031309284172500_B32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaut.2017.09.005","article-title":"Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident \u03b2-cell autoantibodies","volume":"86","author":"Lynch","year":"2018","journal-title":"J Autoimmun"},{"key":"2022031309284172500_B33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/pedi.12547","article-title":"Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk","volume":"19","author":"Mustonen","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"2022031309284172500_B34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diabetes.48.3.460","article-title":"Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study","volume":"48","author":"Ziegler","year":"1999","journal-title":"Diabetes"},{"key":"2022031309284172500_B35","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1464-5491.1999.00186.x","article-title":"Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci","volume":"16","author":"Nejentsev","year":"1999","journal-title":"Diabet Med"},{"key":"2022031309284172500_B36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/jaut.1996.0055","article-title":"Beta-cell autoantibodies in infants and toddlers without IDDM relatives: Diabetes Autoimmunity Study in the Young (DAISY)","volume":"9","author":"Rewers","year":"1996","journal-title":"J Autoimmun"},{"key":"2022031309284172500_B37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.GIM.0000055196.67008.1B","article-title":"Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk","volume":"5","author":"Carmichael","year":"2003","journal-title":"Genet Med"},{"key":"2022031309284172500_B38","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/dc18-2282","article-title":"Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report","volume":"42","author":"Krischer","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031309284172500_B39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1196\/annals.1288.067","article-title":"Population-wide infant screening for HLA-based type 1 diabetes risk via dried blood spots from the public health infrastructure","volume":"1005","author":"Wion","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"2022031309284172500_B40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-3016.2007.00846.x","article-title":"Type 1 diabetes risk analysis on dried blood spot samples from population-based newborns: design and feasibility of an unselected case-control study","volume":"21","author":"Eising","year":"2007","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2022031309284172500_B41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-8227(02)00059-1","article-title":"Evidence of autoantibodies to glutamic acid decarboxylase in oral fluid of type 1 diabetic patients","volume":"57","author":"Todd","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031309284172500_B42","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/pedi.13073","article-title":"HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity","volume":"21","author":"Mikk","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"2022031309284172500_B43","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.2337\/db17-0261","article-title":"The influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history on the progression from multiple autoantibodies to type 1 diabetes: a TEDDY study report","volume":"66","author":"Krischer","year":"2017","journal-title":"Diabetes"},{"key":"2022031309284172500_B44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031309284172500_B45","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00125-018-4561-y","article-title":"Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes","volume":"61","author":"Sioofy-Khojine","year":"2018","journal-title":"Diabetologia"},{"key":"2022031309284172500_B46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/MEG.0b013e328010687d","article-title":"Chronic hepatitis C infection and sicca syndrome: a clear association with HLA DQB1*02","volume":"19","author":"Smyth","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022031309284172500_B47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-3083.2011.02568.x","article-title":"HLA class II alleles and chronic hepatitis C virus infection","volume":"74","author":"Cangussu","year":"2011","journal-title":"Scand J Immunol"},{"key":"2022031309284172500_B48","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2014.01.057","article-title":"The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses","volume":"32","author":"Posteraro","year":"2014","journal-title":"Vaccine"},{"key":"2022031309284172500_B49","article-title":"The peptide vaccine of the future","author":"Nelde","year":"2020","journal-title":"Mol Cell Proteomics"},{"key":"2022031309284172500_B50","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00125-017-4492-z","article-title":"A coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes","volume":"61","author":"Stone","year":"2018","journal-title":"Diabetologia"},{"key":"2022031309284172500_B51","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/vim.2017.0066","article-title":"Antibody affinity against 2009 A\/H1N1 influenza and pandemrix vaccine nucleoproteins differs between childhood narcolepsy patients and controls","volume":"30","author":"Lind","year":"2017","journal-title":"Viral Immunol"},{"key":"2022031309284172500_B52","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/db15-1115","article-title":"Next-generation sequencing reveals that HLA-DRB3, -DRB4, and -DRB5 may be associated with islet autoantibodies and risk for childhood type 1 diabetes","volume":"65","author":"Zhao","year":"2016","journal-title":"Diabetes"},{"key":"2022031309284172500_B53","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00439-013-1285-4","article-title":"Recursive organizer (ROR): an analytic framework for sequence-based association analysis","volume":"132","author":"Zhao","year":"2013","journal-title":"Hum Genet"},{"key":"2022031309284172500_B54","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2337\/db19-0273","article-title":"Eleven amino acids of HLA-DRB1 and fifteen amino acids of HLA-DRB3, 4, and 5 include potentially causal residues responsible for the risk of childhood type 1 diabetes","volume":"68","author":"Zhao","year":"2019","journal-title":"Diabetes"},{"key":"2022031309284172500_B55","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.1073\/pnas.85.21.8111","article-title":"Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study","volume":"85","author":"Morel","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031309284172500_B56","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/db20-0075","article-title":"Motifs of three HLA-DQ amino acid residues (\u03b144, \u03b257, \u03b2135) capture full association with the risk of type 1 diabetes in DQ2 and DQ8 children","volume":"69","author":"Zhao","year":"2020","journal-title":"Diabetes"},{"key":"2022031309284172500_B57","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2337\/diabetes.51.5.1346","article-title":"Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes","volume":"51","author":"Graham","year":"2002","journal-title":"Diabetes"},{"key":"2022031309284172500_B58","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2337\/db20-0038","article-title":"Failed genetic protection: type 1 diabetes in the presence of HLA-DQB1*06:02","volume":"69","author":"Simmons","year":"2020","journal-title":"Diabetes"},{"key":"2022031309284172500_B59","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2337\/db20-0374","article-title":"Next-generation HLA sequence analysis uncovers seven HLA-DQ amino acid residues and six motifs resistant to childhood type 1 diabetes","volume":"69","author":"Zhao","year":"2020","journal-title":"Diabetes"},{"key":"2022031309284172500_B60","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2337\/db18-1128","article-title":"Genetic variation within the HLA-DRA1 gene modulates susceptibility to type 1 diabetes in HLA-DR3 homozygotes","volume":"68","author":"Aydemir","year":"2019","journal-title":"Diabetes"},{"key":"2022031309284172500_B61","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.jtauto.2020.100052","article-title":"Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies","volume":"3","author":"Andersson Sv\u00e4rd","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"2022031309284172500_B62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI74961","article-title":"Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA","volume":"125","author":"Miyadera","year":"2015","journal-title":"J Clin Invest"},{"key":"2022031309284172500_B63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11892-018-1113-2","article-title":"The Environmental Determinants of Diabetes in the Young (TEDDY) study: 2018 update","volume":"18","author":"Rewers","year":"2018","journal-title":"Curr Diab Rep"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/70\/7\/1431\/628361\/dbi180034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/70\/7\/1431\/628361\/dbi180034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:42:27Z","timestamp":1667407347000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/70\/7\/1431\/137859\/Etiology-of-Autoimmune-Islet-Disease-Timing-Is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,28]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dbi18-0034","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}